Literature DB >> 17268129

Gasperini syndrome, a report of two cases.

Miwa Hayashi-Hayata1, Hiroyuki Nakayasu, Mitsuru Doi, Yasuyo Fukada, Takenobu Murakami, Kenji Nakashima.   

Abstract

We report 2 cases of Gasperini syndrome and consider them with the 11 previously reported cases to describe the clinical characteristics of this rare syndrome: Core neurological signs are peripheral facial nerve palsy and abducens nerve palsy of the affected side: Among all cases, imaging demonstrated a small lesion in the mediolateral tegmental pons (10/13 cases of microinfarction; 2/13 cases of microbleeding). We found that the responsible artery in ischemic Gasperini syndrome is mainly the long circumferential branch of the anterior inferior cerebellar artery; Case 1 is the first case thought to be caused by infarction of the basilar artery's paramedian branch.

Entities:  

Mesh:

Year:  2007        PMID: 17268129     DOI: 10.2169/internalmedicine.46.1714

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Medial pontomedullary junctional infarction presenting vertigo, ipsilateral facial paresis, contralateral thermal hypoalgesia and dysphagia without lateral gaze palsy, curtain sign and hoarseness: a case presentation of a novel brain stem stroke syndrome with sensory disturbance-based dysphagia and review of the literature.

Authors:  Yuichiro Yoneoka; Ryo Ikeda; Naotaka Aizawa; Yasuhiro Seki; Katsuhiko Akiyama
Journal:  Oxf Med Case Reports       Date:  2019-01-24

2.  Gasperini Syndrome: A Case Report and Systematic Review and Proposing a New Definition.

Authors:  Riwaj Bhagat; Siddharth Narayanan; Marwa Elnazeir; Thong Diep Pham; Robert Paul Friedland; Kerri Remmel; Wei Liu
Journal:  Case Rep Neurol       Date:  2020-11-13

3.  Gasperini syndrome as clinical manifestation of pontine demyelination.

Authors:  Michael Krasnianski; T Müller; S Zierz; M Winterholler
Journal:  Eur J Med Res       Date:  2009-09-01       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.